A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study: Real‐world effectiveness ...

TASS/. The Health Insurance Administration of South China's Hainan Province has temporarily included the country's oral anti-Covid drug Azvudine into the list of medicine covered by medical insurance.

Fosun Pharma, Genuine Biotech to up output of COVID drug Azvudine with companies January 20, 2023 Shanghai Fosun Pharmaceutical said on Monday it would cooperate with its charity fund and Henan ...